This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Scopus Google Scholar Articles by Bucciarelli, S Articles by Cervera, R PubMed PubMed Citation Articles by Bucciarelli, S Articles by Cervera, R Social Bookmarking                         What's this?

The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome

Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spain

G Espinosa

Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spain

R Cervera

Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Catalonia, Spainrcervera{at}clinic.ub.es

Although less than 1% of patients with the antiphospholipid syndrome (APS) develop the catastrophic variant, its potentially lethal outcome emphasises its importance in clinical medicine today. However, the rarity of this variant makes it extraordinarily difficult to study in any systematic way. To put together all the published case reports as well as the new diagnosed cases from all over the world, an international registry of patients with catastrophic APS (CAPS Registry) was created in 2000 by the European Forum on Antiphospholipid Antibodies. Currently, it documents the entire clinical, laboratory and therapeutic data of more than 300 patients whose data has been fully registered. This registry can be freely consulted at the Internet (http://www.med.ub.es/MIMMUN/FORUM/CAPS.HTM), and it is expected that the periodical analysis of these data will allow us to increase our knowledge of this condition.

Key Words: anticardiolipin antibodies • antiphospholipid antibodies • antiphospholipid syndrome • catastrophic antiphospholipid syndrome • lupus anticoagulant

Lupus, Vol. 18, No. 10, 905-912 (2009)
DOI: 10.1177/0961203309106833


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R Cervera and A Tincani European Working Party on Systemic Lupus Erythematosus and European Forum on Antiphospholipid Antibodies: two networks promoting European research on autoimmunity Lupus, September 1, 2009; 18(10): 863 - 868. [PDF]